Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new approach for realizing the "antioncogram".

P Köpf-Maier1

  • 1Institut für Anatomie, Freie Universität Berlin, Germany.

Life Sciences
|January 1, 1992
PubMed
Summary

This study introduces an organoid culture assay (OCA) to predict patient carcinoma drug response before chemotherapy. The assay tests drug sensitivity and resistance using patient tumor samples in vitro for personalized cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Value of 31P NMR spectroscopy in predicting the response of a xenografted human hypopharynx carcinoma to irradiation.

Journal of cancer research and clinical oncology·2000
Same author

Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.

Anticancer research·1999
Same author

The alkylator treosulfan shows activity towards human renal-cell carcinoma in vivo and in vitro.

In vivo (Athens, Greece)·1998
Same author

Antitumor activity of titanocene amino acid complexes.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine·1996
Same author

Antitumor activity of treosulfan in human lung carcinomas.

Cancer chemotherapy and pharmacology·1996
Same author

5-Fluorouracil metabolism and cytotoxicity after pre-treatment with methotrexate or thymidine in human hypopharynx and colon carcinoma xenografts: a 19F-nuclear magnetic resonance spectroscopy study in vivo.

Cancer chemotherapy and pharmacology·1996

Area of Science:

  • Oncology
  • Cell Biology
  • Biotechnology

Background:

  • Carcinoma drug resistance poses a significant challenge in clinical chemotherapy.
  • Predicting individual patient response to chemotherapy is crucial for effective treatment.

Purpose of the Study:

  • To develop and validate an organoid culture assay (OCA) as an "antioncogram" for predicting patient-specific carcinoma drug sensitivity.
  • To establish an in vitro model for assessing drug resistance in human carcinomas prior to clinical application.

Main Methods:

  • Human carcinoma specimens were disaggregated into single cell suspensions and cultured as organoids on filter sheets.
  • Organoids were exposed to cytostatics (cisplatin) for 2-3 days.
  • Cytotoxic effects were quantified by measuring viable cell fraction (neutral red uptake) relative to total cell mass.

Main Results:

  • The organoid culture assay (OCA) successfully reflected experimentally induced cisplatin resistance in epidermoid hypopharynx carcinoma strains.
  • The assay demonstrated its suitability for rapid and feasible prediction of individual human carcinoma responses to chemotherapy.

Conclusions:

  • The organoid culture assay (OCA) serves as a viable "antioncogram" for personalized cancer therapy.
  • This in vitro method can guide clinical chemotherapy decisions by predicting drug sensitivity and resistance.

Related Experiment Videos